The Effect of Botulinum Toxin on Neuropathic Pain

DOI
  • Ozasa Kana
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University
  • Takizawa Keita
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University
  • Tadokoro Souichirou
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University
  • Okada Akiko
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University
  • Shinozaki Takahiro
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University
  • Noma Noboru
    Department of Oral Medicine, Nihon University School of Dentistry Clinical Research Division, Dental Research Institute, Nihon University

Bibliographic Information

Other Title
  • 神経障害性疼痛に対するボツリヌス神経毒素の効果

Abstract

Purpose: Treatments for classical trigeminal neuralgia include drug therapy, nerve block therapy, and surgical treatment. There is no doubt that carbamazepine is the first choice for medication treatment. However, carbamazepine is also known as a drug with a high incidence of side effects. On the other hand, drug therapy for the pathology of neuropathic pain is challenging and stable effects have not been obtained. Recently, it has been reported that botulinum toxin treatment is effective for intractable trigeminal neuralgia and neuropathic pain. A meta-analysis of botulinum toxin on trigeminal neuralgia and neuropathic pain confirmed its analgesic effect, which was an essential index of the study. On the other hand, since the units used （25-100units） differ for each study, various indicators such as the number of seizures are used for each study. It is positioned botulinum toxin should be used as an additional therapy for carbamazepine-resistant patients. In this review, we describe the efficacy of botulinum toxin for trigeminal neuralgia and neuropathic pain based on clinical studies.

Journal

Keywords

Details 詳細情報について

  • CRID
    1390581401102960768
  • DOI
    10.11264/jjop.16.51
  • ISSN
    18829333
    1883308X
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top